Related references
Note: Only part of the references are listed.Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection
Chloe O. C. Orkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
Susan Swindells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Long-Acting Injectable Cabotegravir plus Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
Giuliano Rizzardini et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2020)
Medication adherence to antiretroviral therapy among newly treated people living with HIV
Yang Yu et al.
BMC PUBLIC HEALTH (2018)
ESTIMATING HEALTH OUTCOMES IN HIV INFECTED PATIENTS TREATED WITH A DUAL REGIMEN OF DOLUTEGRAVIR AND RILPIVIRINE IN EUROPE
O. Darlington et al.
VALUE IN HEALTH (2018)
Treatment and prevention of HIV infection with long-acting antiretrovirals
Laura Benitez-Gutierrez et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
DOLUTEGRAVIR PLUS LAMIVUDINE FOR THE TREATMENT OF NAIVE ADULTS LIVING WITH HIV-1: A UK COST-MINIMIZATION ANALYSIS
T. Ward et al.
VALUE IN HEALTH (2018)
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
David A. Margolis et al.
LANCET (2017)
ESTIMATING LIFE YEARS AND QUALITY-ADJUSTED LIFE YEARS IN HEAVILY TREATMENT-EXPERIENCED (HTE) PATIENTS
P. McEwan et al.
VALUE IN HEALTH (2017)
Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment-Clinical Points of View and Practical Considerations
Simona A. Iacob et al.
FRONTIERS IN PHARMACOLOGY (2017)
Cost effectiveness of 'on demand' HIV pre-exposure prophylaxis for non-injection drug-using men who have sex with men in Canada
Estelle Ouellet et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2015)
The Clinical Role and Cost-Effectiveness of Long-Acting Antiretroviral Therapy
Eric L. Ross et al.
CLINICAL INFECTIOUS DISEASES (2015)
Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens
P. G. Clay et al.
MEDICINE (2015)
Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada
H. Samji et al.
HIV MEDICINE (2015)
Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Naive and Treatment-Experienced Patients in Canada
Nicolas Despiegel et al.
INFECTIOUS DISEASES AND THERAPY (2015)
Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials
Jean B. Nachega et al.
CLINICAL INFECTIOUS DISEASES (2014)
The burden of HIV: insights from the Global Burden of Disease Study 2010
Katrina F. Ortblad et al.
AIDS (2013)
Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis
Ingrid T. Katz et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2013)
HIV transmission rates from persons living with HIV who are aware and unaware of their infection
H. Irene Hall et al.
AIDS (2012)
Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5
Richard Pitman et al.
MEDICAL DECISION MAKING (2012)
Adherence to Antiretroviral Therapy and HIV Transmission Risks: Implications for Test-and-Treat Approaches to HIV Prevention
Seth C. Kalichman et al.
AIDS PATIENT CARE AND STDS (2010)
Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials
Nathan Ford et al.
LANCET (2009)
The costs of HIV Antiretroviral therapy adherence programs and impact on health care utilization
Stephanie L. Sansom et al.
AIDS PATIENT CARE AND STDS (2008)
Relationship between Adherence Level, Type of the Antiretroviral Regimen, and Plasma HIV Type 1 RNA Viral Load: A Prospective Cohort Study
M. Martin et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
A Predictive Model of Health State Utilities for HIV Patients in the Modern Era of Highly Active Antiretroviral Therapy
Teresa L. Kauf et al.
VALUE IN HEALTH (2008)
Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users
RH Needle et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2005)
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy
PR Harrigan et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
The impact of adherence on CD4 cell count responses among HIV-infected patients
E Wood et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Share Paper
